Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
EV to Sales HistoryNormalizing
Percentile Rank71
3Y CAGR+11.6%
5Y CAGR+5.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+11.6%/yr
vs -4.2%/yr prior
5Y CAGR
+5.2%/yr
Recent acceleration
Acceleration
+15.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.68 | +10.8% |
| 2024 | 2.42 | +33.3% |
| 2023 | 1.81 | -5.9% |
| 2022 | 1.93 | -0.7% |
| 2021 | 1.94 | -6.5% |
| 2020 | 2.08 | -2.9% |
| 2019 | 2.14 | -6.4% |
| 2018 | 2.29 | +1.1% |
| 2017 | 2.26 | -28.8% |
| 2016 | 3.18 | - |